TGA Medicinal Cannabis Guidance
TGA Medicinal Cannabis Guidance
Embedded Files
Over the past few years, a number of Australians have expressed interest in the use of cannabis for medicinal purposes. There have only been a limited number of well-designed clinical studies on medicinal cannabis and so it is hard for some doctors to find quality evidence to support decisions to prescribe medicinal cannabis.
The Commonwealth Department of Health, in conjunction with state and territory governments, has helped coordinate the development new clinical guidance documents for prescribers of medicinal cannabis products for treating chemotherapy-induced nausea and vomiting, epilepsy, multiple sclerosis, chronic non-cancer pain and palliative care, as well as an overview document.
Medicinal cannabis products: Patient information
Guidance for the use of medicinal cannabis in Australia: Patient information
Guidance for the use of medicinal cannabis in Australia: Overview
Guidance for the use of medicinal cannabis in Australia: Overview
Guidance for the use of medicinal cannabis in the treatment of multiple sclerosis in Australia
Guidance for the use of medicinal cannabis in the treatment of palliative care patients in Australia
Page updated
Report abuse